Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by LithLoveron Mar 05, 2021 9:05am
172 Views
Post# 32726420

RE:RE:Sedar

RE:RE:Sedar

May 17 is also the day Q1 financials are due.  Q4 March 31.  Meeting is early this year.

in 2020 the annual meeting was Aug 17 and in 2019 and 2018 they were both in June.  
 


MoreUpThanDown wrote: Thanks Constructor. Notice of Annual and Special Meeting, date fixed for the meeting: 17 May 2021. Record Date for notice 29 March 2021... suppose this info will be added to a hopefully "all-in-one" NR soon, but not too soon as the market seems to need to settle down first. Add the meeting to the list of other info... I'm still long and hoping to be at the meeting in person this year since it's certainly to be an interesting one... All IMHO. Do your own DD.

 

<< Previous
Bullboard Posts
Next >>